Pegfilgrastim biosimilar - Reliance Life SciencesAlternative Names: R-TPR-029
Latest Information Update: 21 Sep 2016
At a glance
- Originator Reliance Life Sciences
- Class Granulocyte-macrophage colony-stimulating factors; Polyethylene glycols; Recombinant proteins
- Mechanism of Action Granulocyte stimulants; Haematopoiesis stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Neutropenia